Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons

Journal of Neurochemistry

Volumn 73, Issue 1, 1999, Pages 70-78

  Åkerud, Peter ^a   Alberch, Jordi ^b   Eketjäll, Susanna ^a   Wagner, Joseph ^a   Arenas, Ernest ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Grafts; Hypertrophy; Parkinson's disease; Sprouting; Survival

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NEURTURIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GENETIC ENGINEERING; GROWTH REGULATION; MESENCEPHALON; MOUSE; NONHUMAN; PARKINSON DISEASE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA;

ANIMALS; CELL DIVISION; DOPAMINE; FIBROBLASTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC ENGINEERING; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; MALE; MICE; NERVE DEGENERATION; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURITES; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; NEURTURIN; OXIDOPAMINE; RATS; RATS, INBRED F344; RNA, MESSENGER; SUBSTANTIA NIGRA;

ANIMALIA;

EID: 0033038785     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0730070.x     Document Type: Article

References (52)

1. Arenas E. and Persson H. (1994) Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo. Nature 367, 368-371.
2. Arenas E., Trupp M., Åkerud P. and Ibanez C. F. (1995) GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 15, 1465-1473.
3. Baloh R. H., Tansey M. G., Golden J. P., Creedon D. J., Heuckeroth R. O., Keck C. L., Zimonjic D. B., Popescu N. C., Johnson E. M. Jr., and Milbrandt J. (1997) TrnR2, a novel receptor that mediates neurturin and GDNF signalling through Ret. Neuron 18, 793-802.
4. Baloh R. H., Gorodinsky A., Golden J. P., Tansey M. G., Keck C. L., Popescu N. C., Johnson E. M. Jr., and Milbrandt J. (1998a) GFRalpha3 is an orphan member of the GDNF/neurturin/persephin receptor family. Proc. Natl. Acad. Sci. USA 95, 5801-5806.
5. Baloh R. H., Tansey M. G., Lampe P. A., Fahrner T. J., Enomoto H., Simburger K. S., Leitner M. L., Araki T., Johnson E. M. Jr., and Milbrandt J. (1998b) Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRα3-RET receptor complex. Neuron 21, 1291-1302.
6. Beal M. F., Hyman B. T., and Koroshetz W. (1993) Do defects in mitochondria energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci. 16, 125-131.
7. Beck K., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R., Rosenthal A., and Hefti F. (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373, 339-341.
8. Boewencamp K. E., Hoffman A. F., Gerhardt G. A., Henry M. A., Biddle P. T., Hoffer B. J., and Granholm A.-C. E. (1995) Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J. Comp. Neurol. 355, 479-489.
9. Buj-Bello A., Buchman V. L., Horton A., Rosenthal A., and Davies A. M. (1995) GDNF is an age-specific survival factor for sensory and autonomic neurons. Neuron 15, 821-828.
10. Buj-Bello A., Adu J., Pinon L. G. P., Horton A., Thompson J., Rosenthal A., Chinchetru M., Buchman V. L., and Davies A. M. (1997) Neurturin responsiveness requires a GPI-linked receptor and the Ret receptor tyrosine kinase. Nature 387, 721-724.
11. Cacalano G., Farinas I., Wang L. C., Hagler K., Forgie A., Moore M., Armanini M., Phillips H., Ryan A. M., Reichardt L. F., Hynes M., Davies A., and Rosenthal A. (1998) GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron 21, 53-62.
12. Creedon D. J., Tansey M. G., Baloh R. H., Osborne P. A., Lampe P. A., Fahrner T. J., Heuckeroth R. O., Milbrandt J., and Johnson E. M. Jr. (1997) Neurturin shares receptors and signal transduction pathways with glial cell line-derived neurotrophic factor in sympathetic neurons. Proc. Natl. Acad. Sci. USA 94, 7018-7023.
13. DiPorzio U., Daquet M.-C., Glowinski J., and Prochiantz A. (1980) Effect of striatal cells on in vitro maturation of mesencephalic dopaminergic neurones grown in serum-free conditions. Nature 288, 370-373.
14. Enokido Y., de Sauvage F., Hongo J. A., Ninkina N., Rosenthal A., Buchman V. L., and Davies A. M. (1998) GFR alpha-4 and the tyrosine kinase Ret form a functional receptor complex for persephin. Curr. Biol. 8, 1019-1022.
15. Gash D. M., Zhang Z., Ovadia A., Cass W. A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P. A., Collins F., Hoffer B. J., and Gerhardt G. A. (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380, 252-255.
16. GFRα Nomenclature Committee (1997) Nomenclature of GPI-linked receptors for the GDNF ligand family. Neuron 19, 485.
17. Henderson C. E., Phillips H. S., Pollock R. A., Davies A. M., Lemeulle C., Armanini M., Simpson L. C., Moffet B., Vandlen R. A., Koliatsos V. E., and Rosenthal A. (1994) GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266, 1062-1064.
18. Horger B. A., Nishimura M. C., Armanini M. P., Wang L. C., Poulsen K. T., Rosenblad C., Kirik D., Moffat B., Simmons L., Johnson E. Jr., Milbrandt J., Rosenthal A., Bjorklund A., Vandlen R. A., Hynes M. A., and Phillips H. S. (1998) Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons. J. Neurosci. 18, 4929-4937.
19. Hornykiewicz O. and Kish S. J. (1987) Biochemical pathophysiology of Parkinson's disease. Adv. Neurol. 45, 19-34.
20. Hudson J., Granholm A.-C. E., Gerhardt G. A., Henry M. A., Hoffman A. F., Biddle P. T., Leela N. S., Mackerlova L., Lile J. D., Collins F., and Hoffer B. J. (1995) Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res. Bull. 36, 425-432.
21. Jing S., Wen D., Yu Y., Holst P. L., Luo Y., Fang M., Tamir R., Antonio L., Hu Z., Cupples R., Louis J.-C., Hu S., Altrock B. W., and Fox G. M. (1996) GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF. Cell 85, 1113-1124.
22. Jing S., Yu Y., Fang M., Hu Z., Holst P. L., Boone T., Delaney J., Schultz H., Zhou R., and Fox G. M. (1997) GFRalpha-2 and GFRalpha-3 are two new receptors for ligands of the GDNF family. J. Biol. Chem. 272, 33111-33117.
23. Johansson M., Friedemann M., Hoffer B., and Strömberg I. (1995) Effects of glial cell line-derived neurotrophic factor on developing and mature ventral mesencephalic grafts in oculo. Exp. Neurol. 134, 25-34.
24. Jonsson G. (1983) Chemical lesioning techniques: monoamine neurotoxins, in Handbook of Chemical Neuroanatomy, Vol. I (Bjöklund A. and Hökfelt T., eds), pp. 463-506. Elsevier Science, Amsterdam.
25. Kearns C. M. and Gash D. M. (1995) GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 672, 104-111.
26. Klein R. D., Sherman D., Ho W.-H., Stone D., Bennett G. L., Moffat B., Vandlen R., Simmons L., Gu Q., Hongo J.-A., Devaux B., Poulsen K., Armanini M., Nozaki C., Asai N., Goddard A., Phillips H., Henderson C. E., Takahashi M., and Rosenthal A. (1997) A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. Nature 387, 717-720.
27. Kotzbauer P. T., Lampe P. A., Heuckeroth R. O., Golden G. P., Creedon D. J., Johnson E. M., and Milbrandt J. D. (1996) Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature 384, 467-470.
28. Lin L.-F. H., Doherty D., Lile J., Bektesh S., and Collins F. (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130-1132.
29. Lindner M. D., Winn S. R., Baetge E. E., Hammang J. P., Gentile F. T., Doherty E., McDermott P. E., Frydel E., Ullman M. D., Schallert T., and Emerich D. F. (1995) Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms. Exp. Neurol. 132, 62-76.
30. Mann D. M. A. and Yates P. O. (1983) Pathological basis for neurotransmitter changes in Parkinson's disease. Neuropathol. Appl. Neurobiol. 9, 3-19.
31. Masure S., Cik M., Pangalos M. N., Bonaventure P., Verhasselt P., Lesage A. S., Leysen J. E., and Gordon R. D. (1998) Molecular cloning, expression and tissue distribution of glial-cell-line-derived neurotrophic factor family receptor alpha-3 (GFRalpha-3). Eur. J. Biochem. 251, 622-630.
32. Milbrandt J., de Sauvage F. J., Fahrner F., Baloh R. H., Leitner M. L., Tansey M. G., Lampe P. A., Heuckeroth R. O., Kotzbauer P. T., Simburger K. S., Golden J. P., Davies J. A., Vejsada R., Kato A. C., Hynes M., Sherman D., Nishimura M., Wang L.-C., Vandlen R., Moffat B., Klein R. D., Poulsen K., Gray C., Garces A., Henderson C. E., and Phillips H. S. (1998) Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron 20, 245-253.
33. Naveilhan P., Baudet C., Mikaels Å., Shen L., Westphal H., and Ernfors P. (1998) Expression and regulation of GFRα3, a novel GDNF family receptor. Proc. Natl. Acad. Sci. USA 95, 1295-1300.
34. Neveu I. and Arenas E. (1996) Neurotrophins promote the survival and development of neurons in the cerebellum of hypothyroid rats in vivo. J. Cell Biol. 133, 631-646.
35. Nomoto S., Ito S., Yang L. X., and Kiuchi K. (1998) Molecular cloning and expression analysis of GFR alpha-3, a novel cDNA related to GDNFR alpha and NTNR alpha. Biochem. Biophys. Res. Commun. 244, 849-853.
36. Oppenheim R., Houenou L., Johnson J., Lin L.-F., Li L., Lo A., Newsome A., Prevette D., and Wang S. (1995) Developing motor neurons rescued from programmed cell death by GDNF. Nature 373, 344-346.
37. Pakkenberg H. and Brody H. (1965) The number of nerve cells in the substantia nigra in paralysis agitans. Acta Neuropathol. (Berl.) 5, 320-324.
38. Rees S., Coote J., Stables J., Goodson S., Harris S., and Lee M. G. (1996) Bicistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotic-resistant cells to express recombinant protein. Biotechniques 20, 102-110.
39. Riddle D. R., Lo D. C., and Katz L. C. (1995) NT-4-mediated rescue of lateral geniculate neurons from effects of monocular deprivation. Nature 378, 189-191.
40. Sanicola M., Hession C., Worley D., Carmillo P., Ehrenfels C., Walus L., Robinson S., Jaworski G., Wei H., Tizard R., Whitty A., Pepinsky R. B., and Cate R. L. (1997) Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins. Proc. Natl. Acad. Sci. USA 94, 6238-6243.
41. Sauer H., Rosenblad C., and Björklund A. (1995) Glial cell line-derived neurotrophic factor but not transforming growth factor β3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. Natl. Acad. Sci. USA 92, 8935-8939.
42. Struder L., Spenger C., Seiler R. W., Altar C. A., Lindsay R. M., and Hyman C. (1995) Comparison of the effects of the neurotrophins on dopaminergic neuronal cytoarchitecture in cultures of rat substantia nigra. Eur. J. Neurosci. 7, 223-233.
43. Thompson J., Doxakis E., Pinon L. G., Strachan P., Buj-Bello A., Wyatt S., Buchman V. L., and Davies A. M. (1998) GFRal-pha-4, a new GDNF family receptor. Mol. Cell. Neurosci. 11, 117-126.
44. Tomac A., Lindqvust E., Lin L.-F., Ögren S., Young D., Hoffer B., and Olson L. (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373, 335-339.
45. Treanor J., Goodman L., Desauvage F., Stone D. M., Poulsen K. T., Beck C. D., Gray C., Armanini M. P., Pollock R. A., Hefti F., Phillips H. S., Goddard A., Moore M. W., Bujbello A., Davies A. M., Asai M., Takahashi M., Vandlen R., Henderson C. E., and Rosenthal A. (1996) Characterization of a multicomponent receptor for GDNF. Nature 382, 80-83.
46. Trupp M., Rydén M., Jörnvall H., Timmusk T., Funakoshi H., Arenas E., and Ibáñez C. F. (1995) Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J. Cell Biol. 130, 137-148.
47. Trupp M., Arenas E., Fainzilber M., Nilsson A.-S., Sieber B.-A., Grigoriou M., Kilkenny C., Salazar-Grueso E., Pachnis V., Arumae U., Sariola H., Saarma M., and Ibanez C. F. (1996) Functional receptor for GDNF encoded by the c-ret proto oncogene. Nature 381, 785-788.
48. Trupp M., Belluardo N., Funakoshi H., and Ibanez C. F. (1997) Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-α indicates multiple mechanisms of trophic actions in the adult rat CNS. J. Neurosci. 17, 3554-3567.
49. Tseng J. L., Bruhn S. L., Zurn A. D., and Aebischer P. (1998) Neurturin protects dopaminergic neurons following medial forebrain bundle axotomy. Neuroreport 9, 1817-1822.
50. Widenfalk J., Nosrat C., Tomac A., Westphal H., Hoffer B., and Olson L. (1997) Neurturin and glial cell line-derived neurotrophic factor receptor-β (GDNFR-β), novel proteins related to GDNF and GDNFR-α with specific cellular patterns of expression suggesting roles in the developing and adult nervous system and in peripheral organs. J. Neurosci. 17, 8506-8519.
51. Worby C. A., Vega Q. C., Chao H. H., Seasholtz A. F., Thompson R. C., and Dixon J. E. (1998) Identification and characterization of GFRalpha-3, a novel co-receptor belonging to the glial cell line-derived neurotrophic receptor family. J. Biol. Chem. 273, 3502-3508.
52. Yan Q., Matheson C., and Lopez O. (1995) In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 373, 341-344.